Patents by Inventor Edward A. Schauer

Edward A. Schauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220347210
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Application
    Filed: July 11, 2022
    Publication date: November 3, 2022
    Applicant: Unicycive Therapeutics, Inc.
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Patent number: 11406663
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: August 9, 2022
    Assignee: Unicycive Therapeutics, Inc.
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Publication number: 20200093859
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Application
    Filed: June 6, 2019
    Publication date: March 26, 2020
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Patent number: 10350240
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Grant
    Filed: December 12, 2013
    Date of Patent: July 16, 2019
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Patent number: 9511091
    Abstract: Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: December 6, 2016
    Assignee: Spectrum Pharmaceuticals, Inc.
    Inventors: Rudi E. Moerck, Timothy Malcome Spitler, Edward A. Schauer, Jan Prochazka
  • Publication number: 20160008396
    Abstract: Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
    Type: Application
    Filed: September 21, 2015
    Publication date: January 14, 2016
    Inventors: Rudi E. Moerck, Timothy Malcome Spitler, Edward A. Schauer, Jan Prochazka
  • Patent number: 8961917
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Grant
    Filed: May 12, 2011
    Date of Patent: February 24, 2015
    Assignee: Spectrum Pharmaceuticals, Inc.
    Inventors: Ashok Yeshwant Gore, Edward A. Schauer, Matthew Stewart, Ramsharan Singh
  • Publication number: 20150004086
    Abstract: Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
    Type: Application
    Filed: September 19, 2014
    Publication date: January 1, 2015
    Inventors: Rudi E. Moerck, Timothy Malcome Spitler, Edward A. Schauer, Jan Prochazka
  • Publication number: 20140351083
    Abstract: Included are embodiments for providing a software license. Some embodiments include providing a closed network marketplace that includes a plurality of pieces of licensed software, receiving an indication from a user computing device to acquire a desired licensed software from the closed network marketplace, sending the desired licensed software to the user computing device, and receiving data from an agent application, the agent application causing the user computing device to monitor use of the desired licensed software on the user computing device. In some embodiments, in response to receiving the data from the agent application, providing, by a computing device, a user option may be provided to remove the desired licensed software from the user computing device, thereby effectively returning the software license associated with the desired licensed software such that the software license may be used on another computing device.
    Type: Application
    Filed: May 2, 2014
    Publication date: November 27, 2014
    Applicant: The Procter & Gamble Company
    Inventors: Adam Matthew Lux, Paul Edward Schauer, Timothy Robert Dennedy
  • Patent number: 8852543
    Abstract: Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
    Type: Grant
    Filed: January 7, 2014
    Date of Patent: October 7, 2014
    Assignee: Spectrum Pharmaceuticals, Inc.
    Inventors: Rudi E. Moerck, Timothy Malcome Spitler, Edward A. Schauer, Jan Prochazka
  • Publication number: 20140161702
    Abstract: Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
    Type: Application
    Filed: January 7, 2014
    Publication date: June 12, 2014
    Applicant: SPECTRUM PHARMACEUTICALS, INC.
    Inventors: Rudi E. Moerck, Timothy Malcome Spitler, Edward A. Schauer, Jan Prochazka
  • Publication number: 20140161885
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Application
    Filed: December 12, 2013
    Publication date: June 12, 2014
    Applicant: SPECTRUM PHARMACEUTICALS, INC.
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Patent number: 8715603
    Abstract: Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: May 6, 2014
    Assignee: Spectrum Pharmaceuticals, Inc.
    Inventors: Rudi E. Moerck, Timothy Malcome Spitler, Edward A Schauer, Jan Prochazka
  • Publication number: 20110318410
    Abstract: Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
    Type: Application
    Filed: September 9, 2011
    Publication date: December 29, 2011
    Applicant: SPECTRUM PHARMACEUTICALS, INC.
    Inventors: Rudi E. Moerck, Timothy Malcome Spitler, Edward A. Schauer, Jan Prochazka
  • Publication number: 20110280956
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Application
    Filed: May 12, 2011
    Publication date: November 17, 2011
    Applicant: SPECTRUM PHARMACEUTICALS, INC.
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale
  • Publication number: 20110123628
    Abstract: Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
    Type: Application
    Filed: February 1, 2011
    Publication date: May 26, 2011
    Applicant: SPECTRUM PHARMACEUTICALS, INC.
    Inventors: Rudi E. Moerck, Timothy Malcome Spitler, Edward A. Schauer, Jan Prochazka
  • Publication number: 20100278910
    Abstract: Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
    Type: Application
    Filed: June 14, 2010
    Publication date: November 4, 2010
    Applicant: SPECTRUM PHARMACEUTICALS, INC.
    Inventors: Rudi E. Moerck, Timothy Malcome Spitler, Edward A. Schauer, Jan Prochazka
  • Publication number: 20100196485
    Abstract: Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
    Type: Application
    Filed: December 21, 2009
    Publication date: August 5, 2010
    Applicant: SPECTRUM PHARMACEUTICALS, INC.
    Inventors: Rudi E. Moerck, Timothy Malcome Spitler, Edward A. Schauer, Jan Prochazka
  • Patent number: 7588782
    Abstract: Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: September 15, 2009
    Assignee: Altairnano, Inc.
    Inventors: Rudi E. Moerck, Timothy Malcome Spitler, Edward A. Schauer, Jan Prochazka
  • Publication number: 20090053322
    Abstract: Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
    Type: Application
    Filed: August 22, 2008
    Publication date: February 26, 2009
    Applicant: ALTAIRNANO, INC.
    Inventors: Rudi E. MOERCK, Timothy Malcome Spitler, Edward A. Schauer, Ian Prochazka